Given her post-menopausal age, I knew something was wrong. We would later learn that the culprit was endometrial cancer. My first response was for her to schedule an appointment with her primary ...

Uterine cancer is the fourth most common cancer among women and the most common cancer of a woman's reproductive system. There are two major types of uterine cancer: Adenocarcinoma of the endometrium: ...

Researchers found no significant differences in response or survival outcomes between patients with dMMR and pMMR endometrial cancer.

Potential practice-changing therapies in gynecologic cancer include the emergence of carboplatin, paclitaxel, and PD-1 ...

The following is a summary of “A potential inflammatory biomarker for advanced endometrial cancer treated with lenvatinib ...